378 related articles for article (PubMed ID: 10883667)
1. Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas.
Shi YZ; Hui AM; Takayama T; Li X; Cui X; Makuuchi M
Br J Cancer; 2000 Jul; 83(1):50-5. PubMed ID: 10883667
[TBL] [Abstract][Full Text] [Related]
2. Reduced p21(WAF1/CIP1) expression and p53 mutation in hepatocellular carcinomas.
Hui AM; Kanai Y; Sakamoto M; Tsuda H; Hirohashi S
Hepatology; 1997 Mar; 25(3):575-9. PubMed ID: 9049201
[TBL] [Abstract][Full Text] [Related]
3. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
Qin LF; Ng IO
Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219
[TBL] [Abstract][Full Text] [Related]
4. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
5. p53 and p21WAF1/CIP1 in hepatitis B virus related hepatocarcinogenesis.
Park YN; Chae KJ; Kwon KW; Oh BK; Lee KS; Lee WJ; Park C
Hepatogastroenterology; 2003; 50(53):1292-6. PubMed ID: 14571721
[TBL] [Abstract][Full Text] [Related]
6. Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma.
Naka T; Toyota N; Kaneko T; Kaibara N
Anticancer Res; 1998; 18(1B):555-64. PubMed ID: 9568177
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL
Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405
[TBL] [Abstract][Full Text] [Related]
8. Disruption of p53-p21/WAF1 cell cycle pathway contributes to progression and worse clinical outcome of hepatocellular carcinoma.
Lee TK; Man K; Poon RT; Lo CM; Ng IO; Fan ST
Oncol Rep; 2004 Jul; 12(1):25-31. PubMed ID: 15201954
[TBL] [Abstract][Full Text] [Related]
9. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
[TBL] [Abstract][Full Text] [Related]
10. Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma.
Henkler F; Waseem N; Golding MH; Alison MR; Koshy R
Cancer Res; 1995 Dec; 55(24):6084-91. PubMed ID: 8521397
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
[TBL] [Abstract][Full Text] [Related]
12. [WAF1/CIP1 gene expression in human hepatocellular carcinoma and its relationship with p53 mutation].
Zhu B; Cong W; Wang H
Zhonghua Gan Zang Bing Za Zhi; 1999 Dec; 7(4):217-20. PubMed ID: 10715791
[TBL] [Abstract][Full Text] [Related]
13. p53 missense but not truncation mutations are associated with low levels of p21(CIP1/WAF1) mRNA expression in primary human sarcomas.
Mousses S; Gokgoz N; Wunder JS; Ozcelik H; Bull S; Bell RS; Andrulis IL
Br J Cancer; 2001 Jun; 84(12):1635-9. PubMed ID: 11401317
[TBL] [Abstract][Full Text] [Related]
14. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
[TBL] [Abstract][Full Text] [Related]
15. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
Kralj M; Husnjak K; Körbler T; Pavelić J
Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
[TBL] [Abstract][Full Text] [Related]
16. Genomic and immunophenotypical differences between hepatocellular carcinoma with and without cirrhosis.
Tretiakova MS; Shabani-Rad MT; Guggisberg K; Hart J; Anders RA; Gao ZH
Histopathology; 2010 May; 56(6):683-93. PubMed ID: 20546333
[TBL] [Abstract][Full Text] [Related]
17. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
[TBL] [Abstract][Full Text] [Related]
19. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
[TBL] [Abstract][Full Text] [Related]
20. Reduced p21(WAF1/CIP1) expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladder.
Li X; Hui AM; Shi YZ; Takayama T; Makuuchi M
Hum Pathol; 2001 Aug; 32(8):771-7. PubMed ID: 11521218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
